PlantPharm BioMed Ltd. © 2018 - All rights reserved.

The Breakthrough

The Company’s first vaccine uses genetically edited potatoes as the production host designed to carry the HBsAg antigen (recombinant Hepatitis B antigen) in its genome.


As the potato grows it also multiplies the HBsAg antigen it carries. Therefore tons of these specialized potatoes translates into millions of doses of Hepatitis B vaccinations produced at a very modest cost per dose. The Company has achieved a breakthrough in the controlled-atmosphere production of these vaccine-hosting plants funded by two research grants awarded by the National Institutes of Health (NIH).


As a result the Company has successfully created a new production platform for biopharmaceuticals using its proprietary plant growth system.